GlaxoSmithKline consolidates Philadelphia-area facilities; BioClinica and CoreLab Partners merge;

 @FierceBiotech: From GenoMine test spots three new kidney cancer biomarkers. Story | Follow @FierceBiotech

@JohnCFierce: FDA proposes to dramatically lower the bar on Alzheimer's drugs. Story | Follow @JohnCFierce

@RyanMFierce: Mesoblast, developer of stem cell therapy for degenerative spine, landed A$170M. Good for regenerative rx field: Release | Follow @RyanMFierce

> As GlaxoSmithKline officials were telling their employees at Sirtris in Cambridge, MA that they are planning to shutter the office and lay off an unknown number of employees as they move the work to their Philadelphia facilities, the company also detailed plans to consolidate their work space in Philly. Story

> BioClinica, a clinical trial management services firm, announced that JLL Partners and Ampersand Capital Partners have completed their acquisition of BioClinica and CoreLab Partners and combined the two companies under the name BioClinica. Release

> Ligand Pharmaceuticals has inked a global license and supply agreement with Spectrum Pharmaceuticals. Release

Medical Device News

 @FierceMedDev: Sundance sees future for companion Dx to measure drug-related suicide risk. Story | Follow @FierceMedDev

 @MarkHFierce: Huge: Navidea's lymph node Dx mapping agent is the first of its kind to gain the FDA's blessing in 30 years. Article | Follow @MarkHFierce

 @DamianFierce: Add "find a new CFO" to Quest Diagnostics' "stop shrinking" checklist. Release | Follow @DamianFierce

> Intuitive blames rise in da Vinci injury reports on policy change. Story

> J&J's internal docs say recalled hip was defective. Report

> Expert: Device tax risks chasing 146,000 jobs overseas. Item

Pharma News

@FiercePharma: Free generic Lipitor! Wegmans' pharmacy uses atorvastatin as a loss-leader. Cash price? $67.88. Story | Follow @FiercePharma

@EricPFierce: Hikma has started up production at NJ plant that got FDA warning letter, while injectables going gangbusters. Article | Follow @EricPFierce

> GlaxoSmithKline chief says new-drug prices should drop as R&D improves. Story

> Pfizer takes Indian patent fight to Capitol Hill. News

> Novartis rolls out iPhone apps for cancer patients. More

> Ex-J&J chief's 2012 pay outclasses Gorsky's by almost 3-to-1. Article

Pharma Manufacturing News

> Drugmakers press Congress on sequestered fees slated for inspections. Story

> Moves to help ease drug shortages undercut Spectrum. Item

> Mitsubishi pushes into India with Neuland API deal. Article

> EU API law has drugmakers there in panic. Report

> Hikma's injectables biz rides competitors' woes to new heights. More

Vaccines News

> Top 5 Vaccine Companies by Revenue - 2012. Special Report

> Experts weigh in on smallpox preparedness. Article

> Vaccines falter in fight against whooping cough. News

> Narcolepsy link raises doubts about next-gen adjuvants. Story

> Experts weigh in on smallpox preparedness. More

And Finally… A new study finds that 14% of all new mothers suffer from postpartum depression and are rarely treated for it. Study


Suggested Articles

Eli Lilly is combining the oncology team at Lilly Research Laboratories with Loxo Oncology and putting a trio of Loxo execs at the helm.

The failure of SAGE-217 to beat placebo wiped more than 50% off Sage’s share price as investors digested the implications of the data.

The data tee Aurinia up to file for FDA approval next year and go on to address a major unmet medical need.